Indiana Intellectual Property Law

AUGUST 13, 2021

Cross, the Plaintiff is the owner of three design patents for convertible t-shirt designs, U.S. Patent Nos. D/580,633, D/581,136 , and D/341,471 (collectively, the “Patents in Suit”). due to settlement and a Patent Trial and Appeal Board decision regarding the ‘471 Patent. 35 U.S.C. §

Patent Infringement 52

Patent Infringement Design Patent Patent Designs 52

SpicyIP

MARCH 11, 2024

Highlights of the Week Hot-Tubbing in Indian IP Litigation: Delhi High Court Issues Directives in High-Stakes Patent Infringement Case Image from [link] here Recently, the DHC issued directives regarding expert evidence in the Perjeta patent litigation. Anything we are missing out on? Please let us know in the comments below.

Trademark 59

Trademark Registration Copyright Patent 59

Patently-O

FEBRUARY 24, 2022

20-891 (CVSG requested May 3, 2021); Res Judicata and the Patent-Specific Kessler Doctrine : PersonalWeb Technologies, LLC v. 20-1394 (CVSG requested October 4, 2021); Undermining Jury Decisions : Olaf Sööt Design, LLC v. The settlement also included a license to thousands of Qualcomm patents. Patreon, Inc.,

Patent Law 95

Patent Law Law Patent Litigation 95

The IPKat

SEPTEMBER 12, 2021

A primary motivation for Abbott's expedition application was to obtain a UK court decision on the validity of four European patents in order to influence a German court considering infringement of the German EP equivalents and to prevent the problems of the "injunction gap".

Litigation 98

Litigation Patent Marketing Marketing 98

LexBlog IP

APRIL 3, 2023

Further, during five years of negotiation between the parties before Intex filed the CCI complaint, Ericsson had provided to Intex claim charts showing essentiality and a test report showing infringement. Ericsson argued that, under the 2015 EU decision in Huawei v. ” The Court also distinguished a recent UK Interdigital v.

Licensing 52

Licensing Technology Intellectual Property Patent 52

Fish & Richardson Trademark & Copyright Thoughts

JANUARY 11, 2022

2021 saw several important milestones in the biosimilars space, including the much anticipated first interchangeable designations by FDA and the approval of the first ophthalmology biosimilar. Figure 1 below provides an overview of biosimilar approvals by FDA and product launches in the United States from 2015 to 2021. Introduction.

Litigation 52

Litigation Settlement Patent Marketing 52

LexBlog IP

JUNE 7, 2023

SEP Registration The Proposal establishes a “Competence Centre” within the EUIPO (which currently focuses solely on trademarks and design rights) to set up and maintain an EU-wide register for SEPs. If they reject it, they are subject to infringement remedies (including injunctions).

Licensing 52

Licensing Patent Confidentiality Registration 52